Core Viewpoint - Auhua Endoscopy (688212.SH) announced a significant change in shareholder equity, with a reduction in shares held by major shareholders, which may indicate a shift in investment strategy or liquidity needs [1][3]. Shareholder Equity Changes - As of June 16, 2025, Xiaozhou Optoelectronics reduced its holdings by 414,950 shares, decreasing its total shares from 41,822,800 to 41,407,850, representing a drop from 31.06% to 30.75% of the total share capital [1][2]. - The reduction in shares was executed through centralized bidding, with a total transaction value of approximately 20.8554 million yuan based on the weighted average price of 50.26 yuan per share on June 16 [1][2]. Financial Performance - In 2024, Auhua Endoscopy reported total revenue of 750 million yuan, reflecting a year-on-year growth of 10.54%. However, the net profit attributable to shareholders decreased by 63.68% to 21.0122 million yuan [4]. - The first quarter of 2025 showed a decline in revenue to 124 million yuan, down 26.92% year-on-year, with a net loss of 28.7915 million yuan compared to a profit of 2.7595 million yuan in the same period last year [5].
澳华内镜实控人方套现2086万元 近1年1期扣非亏损